Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 3
1980 14
1981 16
1982 23
1983 18
1984 25
1985 26
1986 39
1987 45
1988 37
1989 60
1990 73
1991 112
1992 122
1993 153
1994 206
1995 199
1996 217
1997 281
1998 279
1999 296
2000 389
2001 463
2002 601
2003 776
2004 973
2005 1305
2006 1478
2007 1764
2008 2142
2009 2520
2010 3112
2011 3630
2012 4360
2013 4969
2014 5803
2015 6661
2016 6996
2017 7562
2018 8831
2019 10131
2020 11816
2021 13192
2022 15642
2023 15012
2024 15277
2025 159

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132,432 results

Results by year

Filters applied: . Clear all
Page 1
Escharotomy.
Zhang L, Labib A, Hughes PG. Zhang L, et al. 2023 Aug 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Aug 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29489153 Free Books & Documents.
AK112, a novel PD-1/VEGF bispecific antibody, in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC): an open-label, multicenter, phase II trial.
Zhao Y, Chen G, Chen J, Zhuang L, Du Y, Yu Q, Zhuang W, Zhao Y, Zhou M, Zhang W, Zhang Y, Wan Y, Li W, Song W, Wang ZM, Li B, Xia M, Yang Y, Fang W, Huang Y, Zhang L. Zhao Y, et al. Among authors: zhang l. EClinicalMedicine. 2023 Aug 3;62:102106. doi: 10.1016/j.eclinm.2023.102106. eCollection 2023 Aug. EClinicalMedicine. 2023. PMID: 37593227 Free PMC article.
Functional diversification of a wild potato immune receptor at its center of origin.
Torres Ascurra YC, Zhang L, Toghani A, Hua C, Rangegowda NJ, Posbeyikian A, Pai H, Lin X, Wolters PJ, Wouters D, de Blok R, Steigenga N, Paillart MJM, Visser RGF, Kamoun S, Nürnberger T, Vleeshouwers VGAA. Torres Ascurra YC, et al. Among authors: zhang l. Science. 2023 Aug 25;381(6660):891-897. doi: 10.1126/science.adg5261. Epub 2023 Aug 24. Science. 2023. PMID: 37616352
Toward automation of germline variant curation in clinical cancer genetics.
Ravichandran V, Shameer Z, Kemel Y, Walsh M, Cadoo K, Lipkin S, Mandelker D, Zhang L, Stadler Z, Robson M, Offit K, Vijai J. Ravichandran V, et al. Among authors: zhang l. Genet Med. 2019 Sep;21(9):2116-2125. doi: 10.1038/s41436-019-0463-8. Epub 2019 Feb 21. Genet Med. 2019. PMID: 30787465 Free PMC article.
Envonalkib versus crizotinib for treatment-naive ALK-positive non-small cell lung cancer: a randomized, multicenter, open-label, phase III trial.
Yang Y, Min J, Yang N, Yu Q, Cheng Y, Zhao Y, Li M, Chen H, Ren S, Zhou J, Zhuang W, Qin X, Cao L, Yu Y, Zhang J, He J, Feng J, Yu H, Zhang L, Fang W. Yang Y, et al. Among authors: zhang l. Signal Transduct Target Ther. 2023 Aug 14;8(1):301. doi: 10.1038/s41392-023-01538-w. Signal Transduct Target Ther. 2023. PMID: 37574511 Free PMC article. Clinical Trial.
132,432 results
You have reached the last available page of results. Please see the User Guide for more information.